Daigo (Liquid) Instructions for Use
Marketing Authorization Holder
Fyodorov Dmitry Vyacheslavovich, Sole Proprietor (Russia)
Manufactured By
B&S Corporation, Co. Ltd. (Japan)
Contact Information
B&S Corporation, Co. Ltd. (Japan)
Dosage Form
| Daigo | Oral liquid: sachets 5 ml 30 pcs. |
Dosage Form, Packaging, and Product Composition
Liquid for oral administration, transparent, odorless, with a characteristic sourish taste.
Composition: fermented soy milk extract (culture fluid of 16 strains of lactic acid bacteria of the genus Lactobacillus), acidity regulators (lactic acid (E270), citric acid (E330)), menaquinone (vitamin K2).
Nutritional value (per 100 ml): fats – 0 g, proteins – 0 g, carbohydrates – 1.1 g.
Energy value: 4 kcal.
Does not contain live bacteria.
Does not contain GMOs.
5 ml – sachets (30) – cardboard boxes.
Therapeutic Category
Dietary supplement for restoring intestinal microflora
Properties
Metabiotic, helps restore gastrointestinal tract function and balance intestinal microflora.
The product consists of secretory secretions (bioregulators) obtained through co-cultivation of 16 strains of lactic acid bacteria of the genus Lactobacillus, with the addition of lactic acid and citric acid. Daigo is also an additional source of vitamin K2 – one of the metabolites of lactic acid bacteria. Daigo does not contain live lactobacilli.
Secretory secretions of lactobacilli revive the body’s own, unique intestinal microflora and promote the reproduction of beneficial bacteria, while simultaneously suppressing pathogenic microflora. Thus, pathogenic bacteria are replaced by beneficial ones, and the intestinal environment gradually improves.
Bacterial bodies – cellular substance, activates intestinal immune cells (Peyer’s patches) and helps stimulate the immune system, aiding in the control of immune balance throughout the body.
Vitamin K2 (menaquinone) is necessary for calcium absorption and blood clotting regulation. Some protein substances essential for our body can only be synthesized in the presence of menaquinone. Menaquinone supports cardiovascular health by redistributing calcium from the blood into bone tissue, regulating blood viscosity and coagulability. Consuming sufficient vitamin K2 prevents the formation of hard fatty deposits on the walls of blood vessels and arteries, ensuring normal blood circulation and protecting the heart. Vitamin K2 helps prevent calcification of coronary arteries, reduces the risk of coronary artery disease and other cardiovascular diseases. An additional effect resulting from improved vascular condition is the reduction of oxidative stress and improved brain function.
Bone and dental health directly depend on calcium level regulation. Menaquinone not only improves the absorption of this mineral but also helps transport it precisely to those areas of the body where calcium is most needed. The cause of brittle bones and teeth can be not only a calcium deficiency but also a lack of vitamin K2.
The use of Daigo product helps improve conditions in dysbiosis, chronic gastrointestinal diseases, allergic diseases, during antibacterial therapy, as well as in the treatment of diseases associated with Helicobacter pylori.
Scope of Application
Of Daigo product
As a dietary supplement – an additional source of vitamin K2, for the following diseases and conditions
- Dysbiosis of various origins;
- Prevention and treatment of diseases associated with Helicobacter pylori;
- Chronic gastrointestinal diseases (colitis, gastritis, gastric and duodenal ulcer, irritable bowel syndrome, Crohn’s disease);
- Colon polyps;
- Antibiotic-associated diarrhea;
- Impaired liver function;
- Diabetes mellitus;
- Allergic diseases;
- Undergoing antibacterial, hormonal, and radiation therapy;
- Prevention of complications and improvement of intestinal function during pregnancy;
- Disturbance of the microflora of female genital organs (candidal vaginitis, inflammation of the cervix);
- Stomatitis and dental caries;
- Skin diseases (dryness, diathesis, atopic dermatitis).
ICD codes
| ICD-10 code | Indication |
| A04.7 | Enterocolitis due to Clostridium difficile |
| B37.3 | Candidiasis of vulva and vagina |
| B98.0 | Helicobacter pylori as the cause of diseases classified elsewhere |
| D12 | Benign neoplasm of colon, rectum, anus and anal canal |
| E14 | Unspecified diabetes mellitus |
| K02 | Dental caries |
| K12 | Stomatitis and related lesions |
| K25 | Gastric ulcer |
| K26 | Duodenal ulcer |
| K29 | Gastritis and duodenitis |
| K50 | Crohn's disease [regional enteritis] |
| K51 | Ulcerative colitis |
| K52.9 | Noninfective gastroenteritis and colitis, unspecified |
| K58 | Irritable bowel syndrome |
| K63.8 | Other specified diseases of intestine |
| K76.9 | Liver disease, unspecified |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| N72 | Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis) |
| N77.1 | Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere |
| N89.8 | Other noninflammatory disorders of vagina |
| R23.8 | Other and unspecified skin changes |
| T78.4 | Allergy, unspecified |
| Y40 | Systemically acting antibiotics |
| Y42 | Hormones and their synthetic substitutes and antagonists, not elsewhere classified |
| Y84.2 | Radiological procedure and radiotherapy |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
The product is taken orally before, during, or after meals, as well as on an empty stomach. Before use, the required dose of the product should be diluted in a glass of water.
The dose is set depending on age and increased/decreased as necessary
- For breastfed infants – the nursing mother should take 1 sachet/day;
- For formula-fed infants – add a few drops of the product to the formula (once/day);
- For children aged 2 to 3 years – 1/5 sachet (1 ml)/day;
- For children aged 3 to 6 years – 1/2 sachet (2.5 ml)/day;
- For children aged 6 to 10 years – 1 sachet (5 ml)/day;
- adults and children over 10 years are prescribed 3-5 sachets/day daily;
The recommended course of administration is 3 months. For solving some problems, a longer course of administration may be required – from 4 months to 1 year.
For prevention, the product can be used continuously.
Side Effects
No side effects have been identified.
Contraindications
- Individual intolerance to the components;
- Pregnancy;
- Breastfeeding period.
Special Instructions
Dietary supplement, not a medicinal product.
Drug Interactions
Daigo can be taken simultaneously with other medications, however, it is recommended to consult with your doctor beforehand.
Dispensing Status
Places of sale are determined by the national legislation of the member states of the Eurasian Economic Union.
Storage Conditions
The product should be stored in a dry place, protected from sunlight, in a cool place at a temperature from 0°C (32°F) to 25°C (77°F).
Shelf Life
Shelf life – 3 years.
After opening the sachet, the product should be consumed within the day.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Picamilon pills 50mg, 60pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Phenibut-Vertex pills 250mg, 20pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Fenotropil pills 100mg, 60pcs
Mildronate capsules 500mg, 90pcs
Cortexin, 10mg, 5ml, 10pcs
Kagocel pills 12mg, 30pcs
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs
Actovegin pills 200mg, 50pcs
Belosalic, lotion solution for external use spray 100ml 